# Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

> **NCT00003199** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 50 (actual)

## Conditions studied

- Estrogen Receptor-negative Breast Cancer
- Estrogen Receptor-positive Breast Cancer
- Inflammatory Breast Cancer
- Male Breast Cancer
- Progesterone Receptor-negative Breast Cancer
- Progesterone Receptor-positive Breast Cancer
- Stage IIIB Breast Cancer
- Stage IV Breast Cancer

## Interventions

- **DRUG:** tamoxifen citrate
- **DRUG:** busulfan
- **DRUG:** thiotepa
- **DRUG:** melphalan
- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** sargramostim
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003199
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003199, "Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*